Massive registry study aims to unlock secrets of rare thyroid cancer
NCT ID NCT04216732
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study uses a large registry of 2030 people with medullary thyroid cancer to track how the disease develops and spreads. Researchers will collect medical records, genetic data, and patient surveys to better understand the cancer's natural history. The goal is to improve how advanced medullary thyroid cancer is managed, but no new treatments are being tested.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better understand how medullary thyroid cancer progresses, potentially leading to improved treatment strategies and patient care.
- What could go wrong
- This is an observational study, not a treatment trial. It collects data only and does not test any new drug or therapy, so it cannot directly improve outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED THYROID GLAND MEDULLARY CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
University of California San Francisco
RECRUITINGSan Francisco, California, 94143, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Massive database study probes link between popular diabetes drugs and rare thyroid cancer
- New imaging agent could improve detection of rare cancers
- New hope for advanced thyroid cancer: drug shows tumor-shrinking promise
- New radioactive therapy targets hard-to-treat thyroid cancer
- New hope for rare cancers? drug combo shows promise in early trial
- Thyroid cancer patients may spend less time in discomfort with simple phone calls